The Twenty-Year History of a Plant-Based Hepatitis B Vaccine: Stuttering or Hopeful?

• J Huang

  English

  Author

• S Ertekin,

  English

  Author

Even though effective immunizations have been used for almost 30 years, hepatitis B is still a
frequent human illness. Plants were thought to offer an alternate source of vaccinations, mostly to be
taken orally. No effective plant-based anti-HBV vaccine has been created in 20 years of efforts. Due to
oral tolerance acquisition, immunization experiments involving the ingestion of raw plant tissue coupled
with injection or just oral delivery of lyophilized tissue were either unfeasible or inadequate. Purified
HBV antigens made from plants were very immunogenic when administered, but their yields were
originally too low for use. However, because knowledge and technology have advanced, novel anti-HBV
vaccines derived from plants may now be presented. It is possible to effectively synthesize all HBV
antigens in either transient or stable expression methods. Injection vaccine processing has been designed
and only has to be properly finished. Similar to the current commercial vaccines, purified antigens may be
administered via injection. Plant tissue that has been lyophilized, removed, and turned into tablets, etc.,
may be used as a boosting vaccine, even if oral vaccines still need to be improved. Additionally,
preliminary studies suggest that a successful parenteral-oral vaccination method may incorporate both
vaccines. Oral formulations of anti-HBV plant-based vaccines nevertheless provide promising
opportunities for a partial replacement of injectable vaccinations.

• pdf